Medical News Today ("30 Years Contributing To The Health And Wealth Of EU Citizens") reports the speech given on the occasion of EFPIA's 30th anniversary Annual General Meeting by its President, Bayer HealthCare CEO Arthur J. Higgins. Calling a new spirit of cooperation and partnership between the pharmaceutical industry and the stakeholder community, Higgins cited the Innovative Medicines Initiative as a good example of partnership to accelerate the R&D of new medicines. Enumerating the EFPIA's achievements over the past three decades he specifically mentioned the Supplementary Protection Certificate, introduced in the early '90s to compensate for the long time required for marketing authorisation and providing up to five additional years of patent protection.
Tuesday, 24 June 2008
30 years on, EFPIA President sees SPC as a milestone
Medical News Today ("30 Years Contributing To The Health And Wealth Of EU Citizens") reports the speech given on the occasion of EFPIA's 30th anniversary Annual General Meeting by its President, Bayer HealthCare CEO Arthur J. Higgins. Calling a new spirit of cooperation and partnership between the pharmaceutical industry and the stakeholder community, Higgins cited the Innovative Medicines Initiative as a good example of partnership to accelerate the R&D of new medicines. Enumerating the EFPIA's achievements over the past three decades he specifically mentioned the Supplementary Protection Certificate, introduced in the early '90s to compensate for the long time required for marketing authorisation and providing up to five additional years of patent protection.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment